ArticleTropical medicine and infectious disease2018
Melioidosis in Sri Lanka.
Article in Tropical medicine and infectious disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 29 citations in OpenAlex.
- Seroprevalence of melioidosis and its associated risk factors -A population-based study in Odisha, Eastern India.Current research in microbial sciences · 2025Article
- Review
- Multiple liver, splenic and psoas abscesses due to melioidosis: A case report.SAGE open medical case reports · 2024Article
- Burden of melioidosis in India and South Asia: Challenges and ways forward.The Lancet regional health. Southeast Asia · 2022Review
- A rare case of melioidosis presenting as myositis in Sri Lanka.BMC infectious diseases · 2022Article
- The Epidemiology of Melioidosis and Its Association with Diabetes Mellitus: A Systematic Review and Meta-Analysis.Pathogens (Basel, Switzerland) · 2022Article
- Article
- Biogeography and genetic diversity of clinical isolates of Burkholderia pseudomallei in Sri Lanka.PLoS neglected tropical diseases · 2021Article
- Melioidosis-a disease of socioeconomic disadvantage.PLoS neglected tropical diseases · 2021Article
- Nonclonal Burkholderia pseudomallei Population in Melioidosis Case Cluster, Sri Lanka.Emerging infectious diseases · 2021Article
- Severe Sepsis with Multiorgan Failure due to Melioidosis: A Lesson to Learn.Case reports in medicine · 2021Article
- An increase in p62/NBR1 levels in melioidosis patients of Sri Lanka exhibit a characteristic of potential host biomarker.Journal of medical microbiology · 2020Article
- Melioidosis after a long silence in Sri Lanka: an environmental hazard and dilemma in diagnosis, with recovery and longitudinal follow-up for 13 years: a case report.Journal of medical case reports · 2020Article
- Human Melioidosis.Clinical microbiology reviews · 2020Review
- A rare case of Sweet syndrome secondary to melioidosis.BMC dermatology · 2019Article
- Whole-Genome Sequences of Eight Clinical Isolates of Burkholderia pseudomallei from Melioidosis Patients in Eastern Sri Lanka.Microbiology resource announcements · 2019Article
- Melioidosis with a subdural collection - a case report.BMC infectious diseases · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
Abstract
Until recently, Sri Lanka was not considered a country with endemic melioidosis. However, an increasing number of cases is being reported. National surveillance for melioidosis was instituted after 2008. A total of 250 culture-positive cases was recorded between 2006 and May 2017. Males predominated (71.6%). The age range was wide (2⁻92 years) reflecting a ubiquity of exposure. The majority (201/250, 80%) lived in rural areas. All provinces were affected. Case load increased during the two monsoonal periods (67%). There was representation of every population group including farmers (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.